These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 11181044)
21. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis. Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941 [TBL] [Abstract][Full Text] [Related]
22. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases. Touyz RM; Yao G J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962 [TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells. Maier TJ; Schilling K; Schmidt R; Geisslinger G; Grösch S Biochem Pharmacol; 2004 Apr; 67(8):1469-78. PubMed ID: 15041464 [TBL] [Abstract][Full Text] [Related]
24. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Assmus B; Urbich C; Aicher A; Hofmann WK; Haendeler J; Rössig L; Spyridopoulos I; Zeiher AM; Dimmeler S Circ Res; 2003 May; 92(9):1049-55. PubMed ID: 12676819 [TBL] [Abstract][Full Text] [Related]
25. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation. Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293 [TBL] [Abstract][Full Text] [Related]
26. Divergent phenotypic patterns and commitment to apoptosis of Caco-2 cells during spontaneous and butyrate-induced differentiation. Mariadason JM; Rickard KL; Barkla DH; Augenlicht LH; Gibson PR J Cell Physiol; 2000 Jun; 183(3):347-54. PubMed ID: 10797309 [TBL] [Abstract][Full Text] [Related]
27. The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells. Archer SY; Johnson J; Kim HJ; Ma Q; Mou H; Daesety V; Meng S; Hodin RA Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G696-703. PubMed ID: 16160080 [TBL] [Abstract][Full Text] [Related]
28. Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27(Kip1). Katner AL; Hoang QB; Gootam P; Jaruga E; Ma Q; Gnarra J; Rayford W Prostate; 2002 Sep; 53(1):77-87. PubMed ID: 12210483 [TBL] [Abstract][Full Text] [Related]
29. Contrasting roles of p57(KIP2) and p21(WAF1/CIP1/SDI1) in transplanted human and bovine adrenocortical cells. Thomas M; Popnikolov NK; Scott C; Smith JR; Hornsby PJ Exp Cell Res; 2001 May; 266(1):106-13. PubMed ID: 11339829 [TBL] [Abstract][Full Text] [Related]
30. p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Philipp-Staheli J; Payne SR; Kemp CJ Exp Cell Res; 2001 Mar; 264(1):148-68. PubMed ID: 11237531 [TBL] [Abstract][Full Text] [Related]
31. [Effects of retinoid Ro 40-8757 on human cancer cell lines in vitro]. Lu J; Song JD Ai Zheng; 2002 Oct; 21(10):1051-6. PubMed ID: 12508641 [TBL] [Abstract][Full Text] [Related]
32. Efficient down-regulation of cyclin A-associated activity and expression in suspended primary keratinocytes requires p21(Cip1). Hauser P; Ma L; Agrawal D; Haura E; Cress WD; Pledger WJ Mol Cancer Res; 2004 Feb; 2(2):96-104. PubMed ID: 14985466 [TBL] [Abstract][Full Text] [Related]
33. Tyrosine kinase inhibitors reverse butyrate stimulation of human Caco-2 intestinal epithelial cell alkaline phosphatase but not butyrate promotion of dipeptidyl dipeptidase. Basson MD; Hong F Cell Biol Int; 1998; 22(5):339-44. PubMed ID: 10198153 [TBL] [Abstract][Full Text] [Related]
34. Short-chain fatty acids and colon cancer cells: the vitamin D receptor--butyrate connection. Gaschott T; Stein J Recent Results Cancer Res; 2003; 164():247-57. PubMed ID: 12899527 [TBL] [Abstract][Full Text] [Related]
35. Lovastatin-induced E2F-1 modulation and its effect on prostate cancer cell death. Park C; Lee I; Kang WK Carcinogenesis; 2001 Oct; 22(10):1727-31. PubMed ID: 11577016 [TBL] [Abstract][Full Text] [Related]
36. Expression of 5-lipoxygenase by human colorectal carcinoma Caco-2 cells during butyrate-induced cell differentiation. Wächtershäuser A; Steinhilber D; Loitsch SM; Stein J Biochem Biophys Res Commun; 2000 Feb; 268(3):778-83. PubMed ID: 10679282 [TBL] [Abstract][Full Text] [Related]
37. Effects of arginine butyrate and tributyrylxylitol on cultured human sarcoma cells. Vincent-Fiquet O; Rogez JC; Boitte F; Brazier M; Desmet G Anticancer Res; 1994; 14(5A):1823-8. PubMed ID: 7531414 [TBL] [Abstract][Full Text] [Related]
38. Signal transduction. An arresting tale. Pulverer B Nature; 2000 Apr; 404(6779):714. PubMed ID: 11012331 [No Abstract] [Full Text] [Related]
39. Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Peng L; He Z; Chen W; Holzman IR; Lin J Pediatr Res; 2007 Jan; 61(1):37-41. PubMed ID: 17211138 [TBL] [Abstract][Full Text] [Related]
40. Resistance to butyrate-induced cell differentiation and apoptosis during spontaneous Caco-2 cell differentiation. Mariadason JM; Velcich A; Wilson AJ; Augenlicht LH; Gibson PR Gastroenterology; 2001 Mar; 120(4):889-99. PubMed ID: 11231943 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]